EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The BRIDGE-DS Study: Improved Glycemic Control and Renal Function in Type 2 Diabetes Mellitus Patients Using the Fixed-Dose Combination of Dapagliflozin and Sitagliptin

Animesh Maiti, Arun Kumar Pandey, Shailja Kale, Tirthankar Mukherjee, Amitabh Biswas, Salil Kumar Pal, Ramanan A, J.P. Vignesh, R. Navin, Lakshmana Kumar Nelakuditi, Chandrashekhar Gillurkar, Biplab Bandyopadhyaya und 4 weitere

Journal of Endocrinology and Metabolism · 2025

DOI: 10.14740/jem1055 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Endocrinology and Metabolism, 2025. Verfasst von Animesh Maiti und 15 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Maiti, A., Pandey, A. K., Kale, S., Mukherjee, T., Biswas, A., Pal, S. K., A, R., Vignesh, J., Navin, R., Nelakuditi, L. K., Gillurkar, C., Bandyopadhyaya, B., Detroja, N., Kesarkar, R. N., Prasad, A., & Pednekar, A. (2025). The BRIDGE-DS Study: Improved Glycemic Control and Renal Function in Type 2 Diabetes Mellitus Patients Using the Fixed-Dose Combination of Dapagliflozin and Sitagliptin. Journal of Endocrinology and Metabolism. https://doi.org/10.14740/jem1055

Vancouver

Maiti A, Pandey AK, Kale S, Mukherjee T, Biswas A, Pal SK, et al. The BRIDGE-DS Study: Improved Glycemic Control and Renal Function in Type 2 Diabetes Mellitus Patients Using the Fixed-Dose Combination of Dapagliflozin and Sitagliptin. Journal of Endocrinology and Metabolism. 2025. doi:10.14740/jem1055

BibTeX
@article{Maiti2025,
  author = {Maiti, Animesh and Pandey, Arun Kumar and Kale, Shailja and Mukherjee, Tirthankar and Biswas, Amitabh and Pal, Salil Kumar and A, Ramanan and Vignesh, J.P. and Navin, R. and Nelakuditi, Lakshmana Kumar and Gillurkar, Chandrashekhar and Bandyopadhyaya, Biplab and Detroja, Nilesh and Kesarkar, Rohan Narayan and Prasad, Ashish and Pednekar, Abhijit},
  title = {The BRIDGE-DS Study: Improved Glycemic Control and Renal Function in Type 2 Diabetes Mellitus Patients Using the Fixed-Dose Combination of Dapagliflozin and Sitagliptin},
  journal = {Journal of Endocrinology and Metabolism},
  year = {2025},
  doi = {10.14740/jem1055}
}
Kostenlos starten →